Argielyn, Dequilla .
HRN: 26-40-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2024
CEFUROXIME 500MG (TAB)
12/22/2024
12/28/2024
PO
500mg
BID
SP NSVD WITH RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes